Table of Content

1 Market Overview
1.1 Chronic Urticaria Or Hives Drug Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Chronic Urticaria Or Hives Drug Market Size & Forecast
1.4.1 Global Chronic Urticaria Or Hives Drug Revenue (2019 VS 2023 VS 2030)
1.4.2 Global Chronic Urticaria Or Hives Drug Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 Chronic Urticaria Or Hives Drug Market Drivers
1.5.2 Chronic Urticaria Or Hives Drug Market Restraints
1.5.3 Chronic Urticaria Or Hives Drug Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 AstraZeneca Plc
2.1.1 Business Overview
2.1.2 AstraZeneca Plc SWOT Analysis
2.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Products and Service Offered
2.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Revenue and Gross Margin
2.2 Biofrontera AG
2.2.1 Business Overview
2.2.2 Biofrontera AG SWOT Analysis
2.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Products and Service Offered
2.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Revenue and Gross Margin
2.3 ELORAC Inc.
2.3.1 Business Overview
2.3.2 ELORAC Inc. SWOT Analysis
2.3.3 ELORAC Inc. Chronic Urticaria Or Hives Drug Products and Service Offered
2.3.4 ELORAC Inc. Chronic Urticaria Or Hives Drug Revenue and Gross Margin
2.4 Faes Farma SA
2.4.1 Business Overview
2.4.2 Faes Farma SA SWOT Analysis
2.4.3 Faes Farma SA Chronic Urticaria Or Hives Drug Products and Service Offered
2.4.4 Faes Farma SA Chronic Urticaria Or Hives Drug Revenue and Gross Margin
2.5 Genentech Inc.
2.5.1 Business Overview
2.5.2 Genentech Inc. SWOT Analysis
2.5.3 Genentech Inc. Chronic Urticaria Or Hives Drug Products and Service Offered
2.5.4 Genentech Inc. Chronic Urticaria Or Hives Drug Revenue and Gross Margin
2.6 GlaxoSmithKline Plc
2.6.1 Business Overview
2.6.2 GlaxoSmithKline Plc SWOT Analysis
2.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Products and Service Offered
2.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Revenue and Gross Margin
2.7 J Uriach Y Compania S.A.
2.7.1 Business Overview
2.7.2 J Uriach Y Compania S.A. SWOT Analysis
2.7.3 J Uriach Y Compania S.A. Chronic Urticaria Or Hives Drug Products and Service Offered
2.7.4 J Uriach Y Compania S.A. Chronic Urticaria Or Hives Drug Revenue and Gross Margin
2.8 Mabtech Limited
2.8.1 Business Overview
2.8.2 Mabtech Limited SWOT Analysis
2.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Products and Service Offered
2.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Revenue and Gross Margin
2.9 Merck & Co. Inc.
2.9.1 Business Overview
2.9.2 Merck & Co. Inc. SWOT Analysis
2.9.3 Merck & Co. Inc. Chronic Urticaria Or Hives Drug Products and Service Offered
2.9.4 Merck & Co. Inc. Chronic Urticaria Or Hives Drug Revenue and Gross Margin
2.10 Mycenax Biotech Inc.
2.10.1 Business Overview
2.10.2 Mycenax Biotech Inc. SWOT Analysis
2.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Products and Service Offered
2.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Revenue and Gross Margin
2.11 Novartis AG
2.11.1 Business Overview
2.11.2 Novartis AG SWOT Analysis
2.11.3 Novartis AG Chronic Urticaria Or Hives Drug Products and Service Offered
2.11.4 Novartis AG Chronic Urticaria Or Hives Drug Revenue and Gross Margin
2.12 Panacea Biotec Limited
2.12.1 Business Overview
2.12.2 Panacea Biotec Limited SWOT Analysis
2.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Products and Service Offered
2.12.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Revenue and Gross Margin
3 Global Chronic Urticaria Or Hives Drug Market Competition, by Manufacturer
3.1 Global Chronic Urticaria Or Hives Drug Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Chronic Urticaria Or Hives Drug Players Market Share in 2023
3.2.2 Top 6 Chronic Urticaria Or Hives Drug Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 Chronic Urticaria Or Hives Drug Players Head Office, Business Provided
3.4 Chronic Urticaria Or Hives Drug Mergers & Acquisitions
3.5 Chronic Urticaria Or Hives Drug New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Chronic Urticaria Or Hives Drug Revenue in Value by Type (2019-2030)
4.2 Global Chronic Urticaria Or Hives Drug Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global Chronic Urticaria Or Hives Drug Revenue by Application (2019-2030)
5.2 Global Chronic Urticaria Or Hives Drug Revenue Share by Application (2019-2030)
6 Global Chronic Urticaria Or Hives Drug Market Analysis by Regions
6.1 Global Chronic Urticaria Or Hives Drug Revenue and Market Share by Regions
6.1.1 Global Chronic Urticaria Or Hives Drug Revenue by Regions (2019-2030)
6.1.2 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Regions (2019-2030)
6.2 North America Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
6.3 Europe Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
6.4 Asia Pacific Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
6.5 South America Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
6.6 Middle East and Africa Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
7 North America Chronic Urticaria Or Hives Drug by Country, by Type, and by Application
7.1 North America Chronic Urticaria Or Hives Drug Revenue by Type (2019-2030)
7.2 North America Chronic Urticaria Or Hives Drug Revenue by Application (2019-2030)
7.3 North America Chronic Urticaria Or Hives Drug Revenue and Market Share by Countries
7.3.1 North America Chronic Urticaria Or Hives Drug Revenue in Value by Country (2019-2030)
7.3.2 United States Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
7.3.3 Canada Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
7.3.4 Mexico Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe Chronic Urticaria Or Hives Drug by Country, by Type, and by Application
8.1 Europe Chronic Urticaria Or Hives Drug Revenue by Type (2019-2030)
8.2 Europe Chronic Urticaria Or Hives Drug Revenue by Application (2019-2030)
8.3 Europe Chronic Urticaria Or Hives Drug Revenue and Market Share by Countries
8.3.1 Europe Chronic Urticaria Or Hives Drug Revenue in Value by Country (2019-2030)
8.3.2 Germany Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
8.3.3 France Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
8.3.4 United Kingdom Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
8.3.5 Russia Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
8.3.6 Italy Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
8.3.7 Nordic Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific Chronic Urticaria Or Hives Drug by Country, by Type, and by Application
9.1 Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Type (2019-2030)
9.2 Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Application (2019-2030)
9.3 Asia Pacific Chronic Urticaria Or Hives Drug Revenue and Market Share by Countries
9.3.1 Asia Pacific Chronic Urticaria Or Hives Drug Revenue in Value by Country (2019-2030)
9.3.2 China Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
9.3.3 Japan Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
9.3.4 Korea Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
9.3.5 India Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
9.3.6 Southeast Asia Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
9.3.7 Australia Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America Chronic Urticaria Or Hives Drug by Country, by Type, and by Application
10.1 South America Chronic Urticaria Or Hives Drug Revenue by Type (2019-2030)
10.2 South America Chronic Urticaria Or Hives Drug Revenue by Application (2019-2030)
10.3 South America Chronic Urticaria Or Hives Drug Revenue and Market Share by Countries
10.3.1 South America Chronic Urticaria Or Hives Drug Revenue in Value by Country (2019-2030)
10.3.2 Brazil Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
10.3.3 Argentina Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa Chronic Urticaria Or Hives Drug by Country, by Type, and by Application
11.1 Middle East & Africa Chronic Urticaria Or Hives Drug Revenue by Type (2019-2030)
11.2 Middle East & Africa Chronic Urticaria Or Hives Drug Revenue by Application (2019-2030)
11.3 Middle East & Africa Chronic Urticaria Or Hives Drug Revenue and Market Share by Countries
11.3.1 Middle East & Africa Chronic Urticaria Or Hives Drug Revenue in Value by Country (2019-2030)
11.3.2 Turkey Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
11.3.3 Egypt Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
11.3.5 UAE Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
11.3.6 South Africa Chronic Urticaria Or Hives Drug Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 Chronic Urticaria Or Hives Drug Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Chronic Urticaria Or Hives Drug Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer